Bio-Products' 506c offering will allow the company to sell 1 000 000 shares of its securities to accredited investors. The company will offer 8% convertible preferred stock at US$10 per share, with a preferred minimum investment of US$5000. The offering will be conducted on a best efforts basis through the company's website, where the Private Placement Memorandum and Accredited Investor Questionnaire are located.
Francesca Brindle
Editorial Assistant
Francesca joined Palladian in November 2015 as an Editorial Assistant for Hydrocarbon Engineering and Tanks and Terminals.
Francesca recently graduated from the University of Kent with a BA (Hons) in English Language and Linguistics, and in her spare time enjoys travelling, photography and forest walks.
